Filing Overview
NexPoint Real Estate Finance, Inc. filed a Form 8-K dated August 2, 2022, under Item 5.02. The filing reports a change in the composition of the company’s Board of Directors; it does not provide quarterly or annual financial results.
Business Context and Reporting Period
The company is a Maryland corporation headquartered in Dallas, Texas. Its common stock trades on the New York Stock Exchange under “NREF,” and its 8.50% Series A Cumulative Redeemable Preferred Stock trades under “NREF-PRA.”
Board Appointment and Governance
- Dr. Carol Swain was appointed to the Board on August 2, 2022.
- Her term is scheduled to expire at the company’s 2023 annual meeting of stockholders.
- She was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
- Dr. Swain entered into the company’s standard indemnification agreement for directors.
- She will receive compensation under the company’s existing policy for non-employee directors.
Financial Metrics and Outlook
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating and financial metrics. It also does not report material changes versus a prior comparable period.
Other Disclosures
- The filing states that there were no arrangements or understandings with other persons regarding Dr. Swain’s selection.
- The company reported no transactions or relationships involving Dr. Swain requiring disclosure under Item 404(a) of Regulation S-K.
- The filing includes the company’s standard director indemnification agreement as an incorporated exhibit.
Important Facts to Verify
- Dr. Swain’s committee assignments and participation in future committee activities.
- The director compensation payable under the company’s current non-employee director policy.
- Any subsequent changes to the Board before the 2023 annual meeting.
- Financial performance, leverage, liquidity, and outlook in the company’s separate periodic filings, as this 8-K contains no such information.